epirubicin has been researched along with Cognition Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chai, JW; Chen, VC; Lin, TY; Weng, JC; Yeh, DC | 1 |
| Boogerd, W; Hamburger, HL; Muller, MJ; Schagen, SB; van Dam, FS | 1 |
1 trial(s) available for epirubicin and Cognition Disorders
| Article | Year |
|---|---|
Neurophysiological evaluation of late effects of adjuvant high-dose chemotherapy on cognitive function.
Topics: Alpha Rhythm; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Breast Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Cognition; Cognition Disorders; Cyclophosphamide; Depression; Electroencephalography; Epirubicin; Event-Related Potentials, P300; Evoked Potentials; Fatigue; Fluorouracil; Humans; Intelligence; Least-Squares Analysis; Middle Aged; Neuropsychological Tests; Thiotepa | 2001 |
1 other study(ies) available for epirubicin and Cognition Disorders
| Article | Year |
|---|---|
Predicting chemo-brain in breast cancer survivors using multiple MRI features and machine-learning.
Topics: Adult; Algorithms; Anisotropy; Antineoplastic Agents; Brain; Brain Mapping; Breast Neoplasms; Cancer Survivors; Case-Control Studies; Cognition Disorders; Docetaxel; Epirubicin; Female; Fourier Analysis; Humans; Machine Learning; Magnetic Resonance Imaging; Middle Aged; Regression Analysis; Young Adult | 2019 |